News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Argos Therapeutics, Inc. to Present at Noble Financial Capital Markets' BIOX Life Sciences Exposition



9/20/2012 9:55:43 AM

DURHAM, N.C., Sept. 20, 2012 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today that its Chief Scientific Officer and Vice President, Research and Development, Charles Nicolette, PH.D., is presenting at BIOX: Noble Financial Capital Markets' Life Sciences Exposition to be held at the University of Connecticut, Stamford, Conn., on September 24-25, 2012.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES